KRAS and neoplasm: Intra-tumor heterogeneity was higher in EAS EGFR-mutant-bearing never-smokers than in their EUR equivalents, On the other hand, EUR patients were characterized by more frequent mutations in other driver genes, among them KRAS, as mentioned above.